Echinacoside promotes bone regeneration by increasing OPG/RANKL ratio in MC3T3-E1 cells

Fitoterapia

Volumn 83, Issue 8, 2012, Pages 1443-1450

  Li, Fei ^a   Yang, Yanan ^b   Zhu, Panpan ^a   Chen, Weina ^a   Qi, Dongli ^a   Shi, Xiupu ^a   Zhang, Chunfeng ^a   Yang, Zhonglin ^a   Li, Ping ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b SHANGHAI INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Bone regeneration; Echinacoside; MC3T3 E1 cell; OPG RANKL; Osteoporosis

Indexed keywords

ALKALINE PHOSPHATASE; CALCIUM; COLLAGEN TYPE 1; ECHINACOSIDE; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN;

ANIMAL CELL; ARTICLE; BONE MINERALIZATION; BONE REGENERATION; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG ISOLATION; DRUG SCREENING; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; IN VITRO STUDY; MOUSE; NONHUMAN; PLANT STEM; PRIORITY JOURNAL; PROTEIN SECRETION;

ALKALINE PHOSPHATASE; ANIMALS; BONE REGENERATION; CELL LINE; COLLAGEN TYPE I; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION; GLYCOSIDES; MICE; MOLECULAR STRUCTURE; OSTEOBLASTS; OSTEOCALCIN; OSTEOPROTEGERIN; RANK LIGAND;

CISTANCHE TUBULOSA;

EID: 84870854146     PISSN: 0367326X     EISSN: 18736971     Source Type: Journal    
DOI: 10.1016/j.fitote.2012.08.008     Document Type: Article

References (23)

1. L.M.F. Lucinda, B.J. Vieria, T.T. Oliveira, R.C.S. Sa, V.M. Peters, and J.E.P. Reis Evidences of osteoporosis improvement in Wistar rats treated with Ginkgo biloba extract: a histomorphometric study of mandible and femur Fitoterapia 81 2012 982 987
2. L.N. Li, Z. Zeng, and G.P. Cai Comparison of neoeriocitrin and naringin on proliferation and osteogenic differentiation in MC3T3-E1 Phytomedicine 18 2011 985 989
3. I. Persson, E. Weiderpass, L. Bergkvist, R. Bergstrom, and C. Schairer Risks of breast and endometrial cancer after estrogen and estrogen-progestin replacement Cancer Causes Control 10 1999 253 260
4. S. Davison, and S.R. Davis Hormone replacement therapy: current controversies Clin Endocrinol 58 2003 249 261
5. H. Kobayashi, H. Oguchi, N. Takizawa, T. Miyase, A. Ueno, and K. Usmanghani New phenylethanoid glycosides from Cistanche tubulosa Chem Pharm Bull 35 1987 3309 3314
6. P.F. Tu, B. Wang, T. Deyama, Z.G. Zhang, and Z.C. Lou Analysis of phenylethanoid glycoside of Herba cistanchis by RP-HPLC Acta Pharmacol Sin 32 1997 294 300
7. M. Pennacchio, E. Alexander, Y.M. Syah, and E.L. Ghisalberti The effect of verbascoside on cyclic 3â€,5â€-adenosine monophosphate levels in isolated rat heart Eur J Pharmacol 305 1996 169 171
8. J. Xie, J. Deng, F. Tan, and J. Su Separation and purification of echinacoside from Penstemon baebatus (Can.) Roth by recycling high-speed counter-current chromatography J Chromatogr B 878 2010 2665 2668
9. Y. Ding, H.T. Nguyen, and E.M. Choi Rhusonoside A, a new megastigmane glycoside from Rhus sylvestris, increase the function of osteoblastic MC3T3-E1 cells Planta Med 75 2009 3158 3162
10. L. Jiao, D.P. Cao, L.P. Qin, T. Han, Q.Y. Zhang, and Z. Zhu Antiosteoporotic activity of phenolic compounds from Curculigo orchioides Phytomedicine 16 2009 874 881
11. Y. Horiguchi, T. Nakai, and K. Kume Effects of Bordetella bronchiseptica dermonecrotic toxin on the structure and function of osteoblastic clone MC3T3-E1 cells Infect Immun 59 1991 1112 1116
12. J. Wang, F. Shang, R. Jiang, L. liu, S. Wang, and J. Hou Nitric oxide-donating genistein prodrug: design, synthesis, and bioactivity on MC3T3-E1 cells J Pharmacol Sci 104 2007 82 89
13. S.L. Teitelbaum, M.M. Tondravi, and F.P. Ross Osteoclasts, macrophages and the molecular mechanism of bone resorption J Leukocyte Biol 61 1997 381 388
14. S. Tat, M. Padrines, S. Theoleyre, D. Heymann, and Y. Fortun IL-6, RANKL, TNF-α/IL-1: interrelations in bone resorption pathology Cytokine Growth Factor Rev 15 2004 49 60
15. H. Sudo, H.A. Kodama, Y.J. Amagai, S. Yamamoto, and S. Kasai In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria J Cell Biol 96 1983 191 198
16. H.A. Kodama, Y. Suda, H. Kasai, and S. Yamamoto Establishment of a clonal osteogenic cell line from new bone mouse calvaria Jpn J Oral Biol 23 1981 891 901
17. L.C. Hofbauer, and Heufelder The role of receptor activator of nuclear factor kappa-B ligand and osteoprotegerin in the pathogenesis and treatment of metabolic bone diseases J Clin Endocrinol Metab 85 2000 2355 2363
18. A. Stern, G.A. Laughlin, J. Bergstrom, and E. Barrett-Connor The sex-specific association of serum osteoprotegerin and receptor activator of nuclear factor kappa-B legend with bone mineral density in older adults: the Rancho Bernardo study Eur J Endocrinol 156 2007 555 562
19. C. MacLean, S. Newberry, M. Maglione, M. McMahon, V. Ranganath, and M. Suttorp Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis Ann Intern Med 148 2008 197 213
20. J.K. Paul Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength Curr Opin Pharmacol 5 2005 618 625
21. J. Clover, and M. Gowen Are MG-63 and HOS TE85 human osteosarcoma cell lines representative models of the osteoblastic phenotype? Bone 15 1994 585 591
22. L. Malaval, D. Modrowski, A.K. Gupta, and J.E. Aubin Cellular expression of bone-related proteins during in vitro osteogenesis in rat bone marrow stromal cell cultures J Cell Physiol 158 1994 555 572
23. M.M. Sandberg, H.T. Aro, and E.I. Vuorio Gene expression during bone repair Clin Orthop 289 1993 292 312